Cizzle Biotechnology Holdings Plc
CIZ.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £6 | £6,941 | £4,224 | £4,816 |
| - Cash | £365 | £144 | £478 | £875 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£359 | £6,797 | £3,746 | £3,941 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | £0 | £0 | -£963 | -£3,958 |
| % Margin | – | – | – | – |
| Net Income | -£2 | -£2 | -£910 | -£3,920 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.006 | 0 | -0.003 | -0.024 |
| % Growth | – | 100% | 87.3% | – |
| Operating Cash Flow | -£358 | -£639 | -£872 | -£1,009 |
| Capital Expenditures | £0 | £0 | £0 | -£200 |
| Free Cash Flow | -£358 | -£639 | -£872 | -£1,209 |